Health ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Medications GLP-1 Agonists Clinical Trials GLP-1 Medications Drug Development Semaglutide Obesity Treatments Obesity Drugs

Cheap GLP‑1 Generics Stall in India as U.S. Pills Raise Employer Cost Fears

The pattern suggests price cuts alone will not produce lasting patient use or relieve mounting coverage and spending pressures for employers.

FuelCell Energy Posts Wider Q2 Loss as Data‑Center Pipeline Surges

Brazil Moves to Tighten Rules on GLP‑1 Weight‑Loss Pens as Demand Surges

India’s ‘Mounjaro Bride’ Trend Fuels Pre‑Wedding Use of GLP‑1 Weight‑Loss Shots

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

São Paulo Police Seize Slimming Drugs on Bus and at West-Zone Depot as Crackdown Widens

Lindt Data Shows GLP‑1 Households Buying More, Not Less, Chocolate in the U.S.

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

Serena Williams’ Super Bowl Zepbound Ad Draws Criticism Over Weight-Loss Pitch, Ro Connection

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Weight-Loss Pills Could Trim Airline Fuel Costs, Jefferies Says

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Eli Lilly, Nimbus Sign AI Discovery Deal for Oral Obesity Drugs